Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
History
Sports
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/fd/65/ef/fd65eff7-d661-09f4-30e8-cad03e8b2489/mza_2895587153873541965.jpg/600x600bb.jpg
PeerVoice Oncology & Haematology Video
PeerVoice
214 episodes
2 weeks ago
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Show more...
Science
Education,
How To,
Health & Fitness,
Medicine
RSS
All content for PeerVoice Oncology & Haematology Video is the property of PeerVoice and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Show more...
Science
Education,
How To,
Health & Fitness,
Medicine
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/fd/65/ef/fd65eff7-d661-09f4-30e8-cad03e8b2489/mza_2895587153873541965.jpg/600x600bb.jpg
Steven Horwitz, MD - Relapsed/Refractory Peripheral T-Cell Lymphoma: Reviewing Available and Anticipated Strategies in This Rare Malignancy
PeerVoice Oncology & Haematology Video
20 minutes 7 seconds
2 weeks ago
Steven Horwitz, MD - Relapsed/Refractory Peripheral T-Cell Lymphoma: Reviewing Available and Anticipated Strategies in This Rare Malignancy
Visit https://www.peervoice.com/MQC860 to view the entire programme with slides. After completing “Steven Horwitz, MD - Relapsed/Refractory Peripheral T-Cell Lymphoma: Reviewing Available and Anticipated Strategies in This Rare Malignancy”, participants will be able to: Recognize unmet needs surrounding the management of peripheral T-cell lymphoma (PTCL), including the impact of the disease on patient quality of life (QoL); Assess the clinical significance of clinical trial data evaluating the safety and efficacy of novel treatments for the management of relapsed/refractory (R/R) PTCL; and Implement current consensus best practice approaches to the management of R/R PTCL.
PeerVoice Oncology & Haematology Video
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.